FBRX - Forte Biosciences, Inc.
IEX Last Trade
16
-0.760 -4.750%
Share volume: 72,645
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$16.76
-1.78
-0.10%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-13 | 2024-08-14 | 2024-11-14 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 7.804 M | 12.818 M | 8.629 M | |
| Selling general and admin | 3.451 M | 7.078 M | 2.759 M | |
| Research and development | 4.353 M | 5.740 M | 5.870 M | |
| Total expenses | 7.804 M | 12.818 M | 8.629 M | |
| 64.25% | -32.68% | |||
| Operating income | -7.804 M | -12.818 M | -8.629 M | |
| Ebit | -7.420 M | -12.818 M | -8.392 M | |
| Pretax income | -7.420 M | -12.818 M | -8.392 M | |
| 72.75% | -34.53% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -7.420 M | -12.511 M | -8.392 M | |
| -68.61% | 32.92% |